Repligen | الأصول



Assets تغيير تاريخ
Agilent USD 12.16B 244M 2025-04
Align Technology USD 6.1B 111.78M 2025-03
Bio Techne USD 2.64B 26.16M 2025-03
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Bruker USD 5.93B 122.7M 2025-03
Charles River Laboratories USD 7.58B 54.02M 2025-03
Danaher USD 81.62B 2.5B 2025-06
Dentsply International USD 6.05B 297M 2025-03
Exact Sciences USD 5.71B 217.07M 2025-03
General Electric Aerospace USD 125.26B 1.13B 2025-06
Henry Schein USD 10.48B 262M 2025-03
Illumina USD 6.18B 121M 2025-03
IQVIA Holdings USD 28.63B 1.31B 2025-06
Mettler Toledo International USD 3.23B 5.32M 2025-03
Myriad Genetics USD 1.01B 21.5M 2025-03
Pfizer USD 208.03B 5.37B 2025-03
Repligen USD 2.85B 22.48M 2025-03
Revvity USD 12.36B 31.75M 2025-03
Standard Biotools USD 612.34M 69.19M 2024-12
Thermo Fisher Scientific USD 101.23B 2.19B 2025-06
Waters USD 4.59B 37.78M 2025-03
West Pharmaceutical Services USD 3.95B 334.6M 2025-06


Repligen الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.